Transasia Bio-Medicals receives US FDA registration for in-vitro diagnostic instruments manufactured in Mumbai

Transasia’s ‘Made in India’ products which are currently exported to over 100 countries will now also be available in the US

Transasia Bio-Medicals recently announced that all its in-vitro diagnostic instruments manufactured in Mumbai are now US FDA registered. What this means is that Transasia’s ‘Made in India’ products which are currently exported to over 100 countries will now also be available in the US.

“For over four decades, Transasia Bio-Medicals has been at the forefront of contributing to a ‘self-reliant India’ by developing and manufacturing innovative and affordable diagnostic solutions. Way back in the 1990s, much before the Make in India concept came into existence, Transasia was already manufacturing all its instruments indigenously and received the CE certification, which allowed the use of its products in the European market.” said Suresh Vazirani, Chairman & Managing Director, Transasia-Erba Group.

“Stringent quality systems norms are in place at all our manufacturing facilities. Our Mumbai plant was subjected to rigorous quality system checks and GMP requirements laid down by US FDA authorities as per 20 CFR 820. We are proud that we are recognised as being compliant to global standards and have received the US FDA registration,” said Ravi Kaushik, CEO, Transasia Bio-Medicals.